Physician profile
Vini Singh
NPI 1902293327
$1,684.78
in general payments reported to CMS, 2019-2025
9 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2021: $102 · 2022: $114 · 2023: $176 · 2024: $336 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $501.61 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Alexion Pharmaceuticals, INC. | $245.82 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $221.55 | 2019-2024 | Andexxa |
| Stryker Corporation | $170.52 | 2025 | Flowtriever |
| Vifor Pharma, INC. | $124.84 | 2019 | |
| Allergan, INC. | $117.91 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.17 | 2022 | |
| Abbvie INC. | $102.44 | 2021 | |
| Fresenius USA Marketing, INC. | $85.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vini Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.